Why Guidance Matters
Decades of research confirm one finding: surgical guidance improves joint replacement outcomes. The question is not whether guidance works. The question is who can access it.
Guided vs. Unguided Surgery
Evidence from peer-reviewed publications and joint replacement registries
| Metric | Unguided | Guided |
|---|---|---|
| Implants in Safe Zone | 63% | 95%+ |
| Dislocation Rate | 3.2% | 0.5% |
| Revision Rate (2-year) | 4.8% | 1.2% |
| Variance from Plan | ±7.2° | ±1.8° |
The Access Problem
Current guidance systems—surgical robots and navigation platforms—cost $1M+ upfront. Only 13% of surgeons can access them.
87% operate without guidance. Their patients face higher complication rates.
Our Approach
Zooly delivers surgical guidance through disposable AI sensors. No capital equipment. No infrastructure requirements.
We follow the same clinical principles proven in decades of research. Our technology makes those principles accessible to every surgeon.
Same Clinical Principles. Universal Access.
The evidence behind surgical guidance is clear. Our innovation is making it available to the 87% who currently operate without it.
Validation Roadmap
Completed Milestones
- Working prototype complete
- Real-time motion tracking validated
- Advisory board with clinical oversight
Planned Validation
- Clinical validation studies
- Outcomes data collection
- Registry participation